NCT05621954

Brief Summary

The goal of this clinical trial is to compare telehealth monitoring at home against usual care in patients undergoing planned heart surgery. The main questions it aims to answer are:

  1. 1.Can telehealth improve quality of life prior to surgery
  2. 2.Can telehealth prevent serious deterioration requiring hospital or primary care attendance

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
318

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

November 18, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

April 4, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

May 11, 2025

Status Verified

May 1, 2025

Enrollment Period

2.3 years

First QC Date

October 25, 2022

Last Update Submit

May 7, 2025

Conditions

Keywords

TelehealthRemote MonitoringWaiting ListQuality of Life

Outcome Measures

Primary Outcomes (2)

  • Change from baseline to admission in Healthcare related Quality of Life Change (EQ5D5L)

    EQ5D5L will be measured by electronic questionnaire by the patient or a researcher on their behalf and indexed for representation on a scale from 0 (worst health, equivalent to being dead) - 1 (best health). The difference in measures between baseline (randomisation) and admission for surgery (up to 52 weeks) will be measured.

    From baseline to admission for surgery (up to 52 weeks)

  • Healthcare resource use during waiting list (composite counts of admission to hospital, A&E attendance and primary care appointment utilisation)

    Composite counts of admissions to hospital, Accident \& Emergency hospital attendance, and primary care appointments for this health condition or complications of this health condition adjudicated by the research team. The counts will be accrued from baseline (randomisation) to admission for surgery (up to 52 weeks).

    From baseline (randomisation) to admission for surgery (up to 52 weeks)

Secondary Outcomes (9)

  • Unplanned admissions pre- and post-surgery

    From baseline to discharge from outpatient cardiac surgery service (up to 52 weeks)

  • Diabetes control

    From baseline (randomisation) to admission for surgery (up to 52 weeks)

  • Smoking cessation

    From baseline (randomisation) to admission for surgery (up to 52 weeks)

  • Post-operative Quality of Life Measures

    From discharge from hospital admission to discharge from outpatient cardiac surgery service (up to 52 weeks)

  • Change in post-operative complications

    From discharge from hospital admission to discharge from outpatient cardiac surgery service (up to 52 weeks)

  • +4 more secondary outcomes

Study Arms (2)

Telehealth monitoring

EXPERIMENTAL

Telehealth remote monitoring provided by a specialised service with a monitoring and patient education app featuring: * Symptom, blood pressure, weight, heart rate and oxygen saturation monitoring with optional step counters * Customised algorithms with patient feedback for prehabilitation (e.g. patient self-reporting of symptoms, activities and health-related activities with positive feedback loops and recommendations for self-directed management) * Centralised weekly review and escalation to expedited surgery if deteriorations noted * Post-operative monitoring with symptom, blood pressure, weight, heart rate, oxygen saturation and photographic wound review with optional step counters

Procedure: Telehealth Monitoring

Standard of Care

NO INTERVENTION

Standard of care will be no remote monitoring for patients whilst on the waiting list or after discharge from hospital. Access to tertiary services for advice, information or to report deteriorations will be through conventional existing modes such as printed or online literature provided at the time of outpatient review, telephone access to administrative staff allowing clinical information to be conveyed to the usual care team, and local primary care and emergency services for acute deteriorations. Existing standard of care remote services (e.g. wound monitoring by digital photograph reviews) will continue.

Interventions

Connected devices and smartphone apps to measure symptoms and observations at home, with centralisation of results to a staffed hub

Also known as: Docobo, Remote Monitoring, Doc@Home
Telehealth monitoring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients over 18y referred and accepted for cardiac surgery
  • Able to consent to participate

You may not qualify if:

  • Urgent or emergent surgery
  • Surgery planned within 3 weeks of first cardiac surgery outpatient review

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Liverpool Heart and Chest Hospital

Liverpool, Mersey, L14 3PE, United Kingdom

Location

MeSH Terms

Conditions

Heart Valve DiseasesCoronary Artery Disease

Interventions

Remote Patient Monitoring

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesCoronary DiseaseMyocardial IschemiaArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

TelemedicineDelivery of Health CarePatient Care ManagementHealth Services Administration

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No masking
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Pragmatic, single-centre, individual patient, randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 25, 2022

First Posted

November 18, 2022

Study Start

April 4, 2023

Primary Completion

August 8, 2025

Study Completion

December 1, 2025

Last Updated

May 11, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

There is no plan to make data widely available. However, should a legitimate request be made by bona fide researchers with data protection legislation equivalent to European Union or United Kingdom General Data Protection Regulations (GDPR), this would not be discounted out of hand. Governance procedures to fully anonymise all identifiable details would be required for any individual participant data, but protocols, analytic source code, data collection forms etc would be shared after publication of the study.

Locations